DiagnaMed Holdings Corp. (DGNMF)
Market Closed
7 Aug, 20:00
OTC PINK 
$
0. 04
0
0%
$
1.14M Market Cap
- P/E Ratio
- Div Yield
30,000 Volume
- Eps
$ 0.04
Previous Close Want to track DGNMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
DGNMF closed Friday higher at $0.04, an increase of 0% from Thursday's close, completing a monthly increase of 11.4286% or $0. Over the past 12 months, DGNMF stock lost -19.4215%.
DGNMF is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on CNSX (CAD).
DGNMF Chart
DiagnaMed Holdings Corp. (DGNMF) FAQ
What is the stock price today?
The current price is $0.04.
On which exchange is it traded?
DiagnaMed Holdings Corp. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is DGNMF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.14M.
Has DiagnaMed Holdings Corp. ever had a stock split?
No, there has never been a stock split.
DiagnaMed Holdings Corp. Profile
| Insurance Industry | Financials Sector | Mr. Fabio Chianelli CEO | OTC PINK Exchange | CA25245D1033 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Diagnamed Holdings Corp. is at the forefront of revolutionizing mental health and neurological disorders treatment through its digital health artificial intelligence initiatives. Based out of Toronto, Canada, the company is dedicated to developing and commercializing state-of-the-art digital therapeutics. Leveraging the power of AI, Diagnamed targets the enhancement of patient care in the realms of mental health and neurology, addressing a critical gap in current healthcare solutions.
Products and Services
The company’s innovative portfolio includes:
- CERVAI: A cutting-edge brain health AI platform designed to advance the management and treatment of neurological disorders. CERVAI employs artificial intelligence to provide insights and therapeutic options tailored to the unique neurological profiles of individuals, fostering better outcomes in brain health.
- Health GenAI: This suite of generative AI solutions for the healthcare market integrates OpenAI's ChatGPT. It is crafted to transform the quality and accessibility of healthcare services through advanced AI tools, ensuring healthcare providers and patients have access to the latest in medical AI technology.
- Dr. GENAI: A personal AI medical chatbot, Dr. GENAI is engineered to offer fast and personalized medical information. By understanding a person's unique medical condition, it provides tailored medical advice, aiming to bridge the gap between patients and immediate healthcare guidance.
- Brain Age: An innovative machine-learning solution based on electroencephalogram (EEG) technology, Brain Age is developed to determine an individual's brain age. This tool is intended for both clinical and home use, providing users and healthcare providers with valuable insights into brain health and aging.
Contact Information
Address: 82 Richmond Street East
Phone: 416 800 2684
Website: https://www.diagnamed.com
